Representative before the EPO

Company dna rouse ip limited
no operation time available
2 offices
active in Legal Services

Representative before the EPO

Company dna rouse patents
no operation time available
552.44
2 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna kilburn and strode llp
operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Dayle Anne Callaghan has worked on the following 36 EPO patent applications which have been published in the last five years:

EP12747021

COMPOSITIONS AND METHODS FOR LEACH EXTRACTION OF MICROORGANISMS

IPC classification:
C12P 7/00
Agent:
William Gerrit Arends, Marks & Clerk LLP
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
EXAMINATION REQUESTED
EP12811493

ROBOTIC SURGICAL DEVICES, SYSTEMS AND RELATED METHODS

IPC classification:
G05B 15/00, G05B 19/00
Applicant:
The Board of Regents of the University of Nebraska
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP12772543

METHOD OF EXTRACTING LUTEIN/XANTHOPHYLLS FROM NATURAL MATERIALS AND HIGHLY PURIFIED LUTEIN/XANTHOPHYLLS OBTAINED FROM THE METHOD THEREOF

IPC classification:
C07C 403/24
Applicant:
Chulalongkorn University
Agent:
Cabinet Plasseraud
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
EXAMINATION IN PROGRESS
EP11778722

SELF-LAUNCHING MOVABLE SCAFFOLDING SYSTEM

IPC classification:
E01D 21/00
Agent:
Cabinet Plasseraud
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP14165977

Improved neurturin molecules

IPC classification:
A61K 38/17, A61P 25/00, C07K 14/47, C07K 14/475
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
PATENT GRANTED
EP14179390

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

IPC classification:
A61K 9/107, A61K 9/48, A61K 31/568, A61K 47/12, A61K 47/14, A61K 47/44
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13714069

SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM

IPC classification:
C12N 1/20, C12N 15/70, C12N 15/74, C12N 15/79, C12P 21/02
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Applicant:
The Board of Trustees of The University of Arkansas
Agent:
Marks & Clerk LLP
Agent:
Multiple attorneys, Kilburn & Strode LLP
Agent:
Multiple attorneys, Rouse IP Limited
Status:
EXAMINATION IN PROGRESS
EP13764829

SYSTEMS AND METHODS TO DETERMINE AND MONITOR CHANGES IN RAIL CONDITIONS

IPC classification:
G01N 29/00
Applicant:
The Board of Regents of the University of Nebraska
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13733180

HIGH THROUGHPUT SEQUENCING OF MULTIPLE TRANSCRIPTS OF A SINGLE CELL

IPC classification:
C12Q 1/68
Applicant:
The Board of Regents of the University of Texas System
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13806521

LOCAL CONTROL ROBOTIC SURGICAL DEVICES AND RELATED METHODS

IPC classification:
B25J 9/04, B25J 9/18, B25J 17/02
Applicant:
The Board of Regents of the University of Nebraska
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
PATENT GRANTED
EP13731455

APPARATUS FOR CONVERTING ENERGY FROM FLUID FLOW

IPC classification:
F03B 13/08
Agent:
Multiple attorneys, Kilburn & Strode LLP
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
EXAMINATION IN PROGRESS
EP13823115

METHODS, SYSTEMS, AND DEVICES RELATING TO OPEN MICROFLUIDIC CHANNELS

IPC classification:
B81B 1/00, B81C 1/00
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13828139

DIRECTIONAL ELUTING IMPLANTABLE MEDICAL DEVICE

IPC classification:
A61F 2/82, A61F 2/86, A61F 2/90
Applicant:
South Dakota Board of Regents
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13827790

ASCORBIC ACID-ELUTING IMPLANTABLE MEDICAL DEVICES, SYSTEMS, AND RELATED METHODS

IPC classification:
A61F 2/02
Applicant:
South Dakota Board of Regents
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13827150

ROBOTIC SURGICAL DEVICES, SYSTEMS, AND RELATED METHODS

IPC classification:
A61B 1/313
Applicant:
The Board of Regents of the University of Nebraska
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13794617

A NOVEL TOXIN IN TYPE A CLOSTRIDIUM PERFRINGENS

IPC classification:
A61K 39/08, A61K 39/385, A61P 31/04, A61P 37/04, C07K 14/33, C07K 16/12, C07K 19/00, C12N 15/31, G01N 33/569
Applicant:
University of Guelph
Agent:
William Gerrit Arends, Marks & Clerk LLP
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13844604

GOLD RECOVERY FROM REFRACTORY ORES AND CONCENTRATES

IPC classification:
C22B 3/00, C22B 11/00
Agent:
Marks & Clerk LLP
Agent:
Boult Wade Tennant Ltd
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP11870618

METHODS AND SYSTEMS FOR HANDLING OR DELIVERING MATERIALS FOR NATURAL ORIFICE SURGERY

IPC classification:
A61B 1/018
Applicant:
The Board of Regents of the University of Nebraska
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14756906

ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 25/00, C07K 16/44
Applicant:
United Arab Emirates University
Agent:
David Michael Grant, Marks & Clerk LLP
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14819728

SOFT TISSUE IMPLANT

IPC classification:
A01N 63/00, A61K 35/52, C12N 5/071
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14817208

APPARATUS FOR HANGING DROP DETECTION OF EPIDURAL SPACE PENETRATION

IPC classification:
A61M 5/00
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14846151

E. COLI SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM

IPC classification:
C12N 1/20, C12N 15/70, C12N 15/74, C12N 15/79, C12P 21/02
Applicant:
The Board of Trustees of The University of Arkansas
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14862987

MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF

IPC classification:
A61K 39/00, C12N 5/07, C12P 21/06, C12P 21/08
Applicant:
Zymeworks Inc
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14863869

USE OF FLUORINATED CYCLIC DINUCLEOTIDES AS ORAL VACCINE ADJUVANTS

IPC classification:
A61K 31/7084, A61K 39/39, A61P 31/04, A61P 37/04
Applicant:
National Research Council of Canada
Applicant:
Brock University
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP16153694

FORMULATIONS FOR LYSOSOMAL ENZYMES

IPC classification:
A61K 38/16, A61K 38/17, A61K 38/46, A61K 47/30, A61K 47/34, A61P 3/00
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14821918

SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF

IPC classification:
A61K 35/00, A61K 35/742, A61K 35/744, A61K 35/745
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14866161

BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2

IPC classification:
A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28, C07K 16/46, C12N 5/10, C12N 15/13, C40B 40/08
Applicant:
Zymeworks Inc
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP13895342

CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE

IPC classification:
A61K 31/337, A61K 31/496, A61P 35/00
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15749661

NOVEL FULL SPECTRUM ANTI-DENGUE ANTIBODY

IPC classification:
A61K 39/395, A61K 39/42, C07K 16/00, C12P 21/08
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15765060

CARBOXY-CYCLOPROPYL UNDECANOL COMPOUNDS FOR TREATMENT OF LIVER DISEASE AND OTHER MEDICAL DISORDERS

IPC classification:
A61K 31/194, A61P 1/16, A61P 31/12, A61P 31/18
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15715386

TURBINE ASSEMBLY

IPC classification:
F03B 13/08, F03B 17/06
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP16190858

COMPOSITIONS FOR INFUSION OF TRANSIENTLY ENGRAFTING, SELECTED POPULATIONS OF ALLOGENEIC LYMPHOCYTES

IPC classification:
A61K 38/00, A61P 7/00, A61P 35/00, C12N 5/078
Applicant:
Johns Hopkins University
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15793514

DEIMMUNIZED LYSOSTAPHIN AND METHODS OF USE

IPC classification:
A61K 38/48, A61P 31/04, C12N 9/52
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15734226

MODIFIED LATENCY ASSOCIATED PROTEIN CONSTRUCT

IPC classification:
C07K 14/495, C12N 15/62
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature